Phase 2, randomized, double‐blind study of pracinostat in combination with azacitidine in patients with untreated, higher‐risk myelodysplastic syndromes
暂无分享，去创建一个
J. Reeves | M. Maris | H. Kantarjian | G. Garcia-Manero | F. Ravandi | E. Jabbour | M. Sekeres | G. Roboz | R. Ghalie | J. Essell | R. Komrokji | R. Lyons | A. DeZern | B. Anz | Yasmin M Abaza | G. Montalban-Bravo | R. Boccia | P. Kuriakose | J. Berdeja | B. Heller | D. Wright | S. Babu